- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 279/28 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
Patent holdings for IPC class C07C 279/28
Total number of patents in this class: 39
10-year publication summary
1
|
6
|
6
|
2
|
8
|
2
|
6
|
1
|
2
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Modernatx, Inc. | 1206 |
15 |
The Regents of the University of California | 19517 |
2 |
Duke University | 3011 |
2 |
Chengdu Kaoensi Science and Technology Co., Ltd. | 2 |
2 |
Shanghai ChemPartner Co., Ltd. | 3 |
2 |
Novartis Pharmaceuticals Corporation | 52 |
1 |
Evonik Degussa GmbH | 1557 |
1 |
FUJIFILM Corporation | 28805 |
1 |
Alzchem Trostberg GmbH | 269 |
1 |
Cortexyme, Inc | 13 |
1 |
SABIC Global Technologies B.V. | 4203 |
1 |
Tianjin Hemay Bio-Tech Co., Ltd. | 26 |
1 |
Tianjin Michele Sci-Tech Development Co., Ltd. | 8 |
1 |
Universidade de Vigo | 56 |
1 |
Xenon Pharmaceuticals Inc. | 194 |
1 |
Dezhou University | 41 |
1 |
Evonik Operations GmbH | 4021 |
1 |
Bausch + Lomb Ireland Limited | 677 |
1 |
Thg, LLC | 7 |
1 |
Specialty Operations France | 697 |
1 |
Other owners | 1 |